Skip to content

Simran Demla

NPI 1891465464ActiveIndividual· Internal Medicine· Ft Worth, TX

Internal Medicine in Ft Worth, Texas, licensed in TX, with an NPI issued in September 2021. Part D covered 102 prescriptions written in 2024, 81% of them generic. Dexcom, Inc. was the largest of 2 companies reporting payments in 2025, $35.07 in all, mostly food and beverage.

Overview

NPI1891465464
StatusActive
Entity typeIndividual
Sole proprietorNo
NPI issuedSep 15, 2021
Last updated in NPPESMay 25, 2023
Certified by providerMay 25, 2023

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 10, 2026No match—
New York OMIG · Nov 10, 2026No match—
Ohio Medicaid · Nov 10, 2026No match—
Pennsylvania Medicheck · Nov 10, 2026No match—
Washington HCA · Nov 10, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Order and Referring Only - Internal Medicine (TX)

Part D prescriptions in 2024

Prescriptions (claims)102 · 187 30-day fills
Patients39
Total drug cost$8,315
Generic share81% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$35.07 · 2 payments from 2 companies
  • 2024$49.42 · 1 payment from 1 company

Top paying companies in 2025

CompanyAmountPayments
Dexcom, Inc.$18.971
Neurocrine Biosciences, Inc.$16.101

What the 2025 payments were for

  • Food and Beverage$35.07 · 2 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Internal Medicine providers in Ft Worth

All Internal Medicine providers in Texas →